Log in

Yellow fever: Rio launches mass vaccination campaign

Rio de Janeiro decided on Thursday to advance a mass vaccination campaign against yellow fever, after confirming the day before the first death from the disease in the state of southeastern Brazil.


France / Pharmaceutical Outsourcing: capture of new production and export target

The pharmaceutical outsourcing in France has strengths but will have to preserve existing productions, capture new and grow for export, according to a report conducted for the Directorate General for Enterprise (DGE) and presented Thursday.


Sanofi is working with AstraZeneca on an antibody and will pay up to EUR 615 M

The French pharmaceutical group Sanofi said it had forged an agreement with its British rival AstraZeneca to develop and market a drug for preventing diseases associated with respiratory virus in infants.


Leukemia: Servier and Pfizer get the green light to a study in the US

The pharmaceutical group Servier and Pfizer and biotech Cellectis announced Thursday it had given the green light from the FDA to conduct a clinical development in the United States of UCART19 therapy in the treatment of acute lymphoblastic leukemia (ALL).


Biogen put on biosimilar to strengthen its growth in France

The US biopharmaceutical group Biogen put on its entry into the biosimilars sector to develop its business in France, and strengthen the position of the Hexagon as third countries in terms of sales.


a3p-100pxhaut logo


Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb here )

  group    administrators A3P
& Project Managers

letter   newsletter A3P